NEW YORK (GenomeWeb) – Bruker said today that it has acquired informatics firm Scils and reagents manufacturer InVivo Biotech Services.

Both acquisitions add to Bruker's life sciences portfolio with Scils bringing expertise in areas including analysis and visualization of imaging mass spectrometry data and InVivo providing expertise in manufacturing monoclonal antibodies and recombinant proteins as well as custom immunoassays and research kits.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

NPR reports that with medical data being big business, some companies want to get patients involved.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.